Philpott and Walker: YEAR ONE – We need a proper recovery plan for all ottawacitizen.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ottawacitizen.com Daily Mail and Mail on Sunday newspapers.
2 February 2021 - Wits University
Researchers at the University of Oxford have today published in Preprints with The Lancet an analysis of further data from the ongoing trials of the vaccine.
The Vaccines and Infectious Diseases Analytics Research Unit (VIDA) at Wits University runs the South African Oxford Covid-19 vaccine trial. Professor Shabir Madhi, Executive Director of Wits VIDA and Dean of the Faculty of Health Sciences at the University, leads these trials and he is a co-author in the Preprints.
In releasing the data regarding sustained protection of 76% during the 3-month interval until the second dose, scientists at Oxford reveal that the vaccine efficacy is higher at longer prime-boost intervals, and that a single dose of the vaccine is 76% effective from 22- to up to 90-days post vaccination. The analyses reveal:
COVID19 News - Oxford Covid-19 vaccine shows sustained protection of 76% during 3-month interval until second dose wits.ac.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wits.ac.za Daily Mail and Mail on Sunday newspapers.
DA calls on govt to publicly release its COVID-19 vaccine plans The party on Friday said securing a vaccine for South Africa should be government’s number one priority. FILE: Professor Martin Veller (L), the Dean of the Faculty of Health Sciences at the University of the Witwatersrand (Wits University), receives an experimental vaccine for COVID-19 coronavirus at the Respiratory & Meningeal Pathogens Research Unit (RMPRU) at Chris Hani Baragwanath Hospital in Soweto on 14 July 2020. Six senior clinicians in the Faculty of Health Sciences at Wits University have volunteered to participate in South Africa’s first COVID-19 vaccine trial. Picture: AFP